The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

13 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.EBI
Universidade De Lisboa
Targeting Type 2 Diabetes with C-Glucosyl Dihydrochalcones as Selective Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Synthesis and Biological Evaluation.EBI
Universidade De Lisboa
Optimization of O3-acyl kojic acid derivatives as potent and selective human neutrophil elastase inhibitors.EBI
Universidade De Lisboa
Azetidine-2,4-diones (4-oxo-beta-lactams) as scaffolds for designing elastase inhibitors.EBI
Universidade De Lisboa
Drug discovery in tuberculosis. New drug targets and antimycobacterial agents.EBI
Universidade De Lisboa
Discovery of MDM2-p53 and MDM4-p53 protein-protein interactions small molecule dual inhibitors.EBI
Universidade De Lisboa
Indoloquinolines as scaffolds for the design of potent G-quadruplex ligands.EBI
Universidade De Lisboa
Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.EBI
Universidade De Lisboa
Structure-Function Analysis of Immune Checkpoint Receptors to Guide Emerging Anticancer Immunotherapy.EBI
Universidade De Lisboa
Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer's disease.EBI
Universidade De Lisboa
Monoterpene indole alkaloid azine derivatives as MDR reversal agents.EBI
Universidade De Lisboa
Synthesis and Quantum Chemical Studies of New 4-aminoquinazoline Derivatives as Aurora A/B Kinase Inhibitors.BDB
Southeast University
Structure-based discovery of a new class of Bcl-xL antagonists.BDB
Burnham Institute For Medical Research